Vitrification and slow freezing are two ways of cryopreserving eggs and embryos — cooling them to very low temperatures so they can be stored and warmed later. The short answer is that they take opposite approaches to the same problem. Slow freezing cools gradually in the presence of relatively low concentrations of cryoprotectant, so that water leaves the cell and ice forms mainly in the solution around it. Vitrification uses much higher cryoprotectant concentrations and very rapid cooling, so the solution solidifies into a glass-like state without forming ice crystals.
That difference in mechanism is the reason vitrification has become the usual approach for oocytes and blastocysts in many laboratories. It is also why the method places different demands on the embryology team. Below is a plain explanation of the mechanism, the trade-offs, and the practical questions worth raising with your clinic.
Why ice is the central problem
Cells contain a lot of water. When water freezes slowly, ice crystals form. Those crystals can physically disrupt cell structures, and the changing concentration of solutes as water turns to ice can also stress the cell. Cryopreservation therefore has two broad strategies: control where and how ice forms, or prevent it from forming at all.
Slow freezing follows the first strategy. The sample is cooled in a controlled, gradual way, and the cryoprotectant concentration is kept relatively low. As cooling proceeds, water moves out of the cell and ice forms mainly in the surrounding medium rather than inside the cell. The cell dehydrates in a controlled manner, which limits internal ice damage.
Vitrification follows the second strategy. A high concentration of cryoprotectants, combined with extremely fast cooling, raises the viscosity of the solution so much that it becomes an amorphous, glass-like solid. No meaningful ice crystals form. The cell is effectively suspended in that glassy state until warming.
The trade-offs on each side
Neither method is free of risk, and the trade-offs are different in kind.
| Feature | Slow freezing | Vitrification |
|---|---|---|
| Cryoprotectant concentration | Relatively low | High |
| Cooling rate | Gradual, controlled | Very rapid |
| Ice formation | Occurs mainly outside the cell | Largely avoided; glass-like solid |
| Main technical concern | Ice crystal injury and solution effects | Cryoprotectant toxicity and need for precise, fast handling |
| Demands on the laboratory | Controlled-rate equipment and protocol | Skilled embryologists, consistent technique, carrier devices |
The high cryoprotectant load in vitrification is a real consideration, not a marketing detail. Chemical toxicity from cryoprotectants is one of the main stresses a cell must survive, and it is why the exposure steps are timed carefully and why technique matters. Vitrification is also less forgiving of small errors: the cooling must be fast enough and the handling consistent, which places weight on the embryologist’s skill and the laboratory’s routines. Carrier devices and closed or open systems are part of that picture, and different laboratories make different choices.
Slow freezing, by contrast, is gentler in terms of cryoprotectant exposure but accepts that some ice will form. For cells that tolerate that reasonably, it can work well. For cells that are especially sensitive to ice injury, it is less attractive.
Why vitrification is often used for eggs and blastocysts
Oocytes and blastocysts are large, water-rich cells, and the oocyte in particular is known to be sensitive to cryoinjury. That combination — high water content and sensitivity — is the reasoning usually given for favouring vitrification in these cell types. The rapid cooling and glass-like solidification reduce the opportunity for ice crystals to form and grow.
This is a general explanation of why the method is widely used, not a statement that every laboratory uses it for every case, or that outcomes are guaranteed. Laboratory practice, the specific cell type, and the clinic’s own protocols all matter, and those are questions for the treating team rather than something a general guide can settle.
What happens at warming
Warming is the other half of the process and deserves as much attention as cooling. Vitrified samples must be warmed rapidly and the cryoprotectant removed in a controlled sequence, because the glassy state is only stable while it stays very cold. Slow-frozen samples are thawed according to their own protocol, with the cryoprotectant gradually diluted out.
Survival after warming is the practical measure that matters, and it depends on the whole chain: how the sample was prepared, how it was cooled, how it was stored, and how it was warmed. A clinic’s reported approach to one step tells you little on its own about the others.
What this means for your own eggs or embryos
If you are researching cryopreservation before treatment, the useful move is to find out what will actually happen to your material and who is responsible for each step. Patients can and should ask their treating clinician and embryologist about the method used, the reasoning behind it, and what is known about survival after warming in their laboratory. Those are clinical questions, and the answers belong with the clinical team.
Practical points worth confirming in writing include:
- Which method the laboratory uses for oocytes and for blastocysts, and whether it differs by cell type.
- Whether the laboratory uses an open or closed carrier system, and what that means for your sample.
- What information the clinic can share about warming survival for its own practice, and how it defines and records it.
- Who performs vitrification and warming, and how the laboratory documents each step.
- What the storage agreement covers: duration, fees, renewal terms, and what happens if communication lapses.
It is reasonable to ask for the storage agreement and fee schedule as documents rather than verbal summaries, and to keep your own dated copy of what you signed and paid. If you are comparing quotations, check whether cryopreservation, storage, and warming are listed as separate line items or bundled, since inclusions vary between clinics.
Where PGT fits, and where it does not
Cryopreservation and preimplantation genetic testing are separate steps that are sometimes discussed together because biopsy and freezing often occur in the same treatment cycle. If PGT is part of your plan, the relevant point here is that a biopsy sample is a small number of cells, and a result from that sample is not a whole-embryo diagnosis. Technical factors can contribute to findings, and the meaning of a result — including a mosaic finding — should be discussed with your treating clinician and a genetic counsellor.
PGT is not a guarantee of a successful pregnancy or a healthy child, and it is not necessary for every patient. Whether it applies to your situation is a clinical judgement based on your history, and it is separate from the question of how eggs or embryos are frozen.
Coordinating the practical side
The clinical interpretation of your cryopreservation plan stays with your treating embryologist and clinician. What a coordination service can do is help you prepare the questions, organise your existing records, request written confirmation of storage terms and fees, and keep track of what has and has not been confirmed. If you are travelling to Thailand for treatment, it can also help align appointment requests and language needs with confirmed hospital arrangements, and later help request records and follow-up answers after you return home. Scope and any fees for tailored support are confirmed individually.
If you would like to start by setting out your goals, timing, and the questions you want answered, you can request a case review. For background on the wider process, see embryo freezing in Thailand, and if cost is part of your planning, the breakdown of what PGT-A testing cost includes and excludes and the guide to what a typical IVF package in Thailand includes can help you frame comparison questions.
Frequently asked questions
Does vitrification damage eggs or embryos?
Any cryopreservation step carries some risk, and vitrification is no exception. The main concerns are cryoprotectant toxicity and the need for fast, consistent technique. How a particular sample fares depends on the whole chain of preparation, cooling, storage and warming, and on the laboratory's practice. Your treating embryologist is the right person to discuss the risks relevant to your material.
Can I ask my clinic which method it uses?
Yes. Asking which method is used for your eggs or embryos, why, and how warming survival is recorded is a reasonable clinical question for your treating clinician or embryologist. It is also reasonable to ask for the storage agreement and fee terms in writing.